Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1003 of 5804
-
New cocktail of drugs takes on tough pancreatic cancer
Disease control Recruiting nowThe researchers are doing this study to find out whether ELI-002 7P in combination with mFOLFIRINOX, with or without tislelizumab, is a safe treatment approach in people who have pancreatic ductal adenocarcinoma (PDAC) with a KRAS mutation. In addition, the researchers are doing …
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New hope for IIH headache sufferers: migraine drug tested in landmark trial
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if eptinezumab can reduce headache frequency and headache-related disability in adults with idiopathic intracranial hypertension (IIH) and chronic headache. It will also evaluate the safety and tolerability of eptinezumab in this patien…
Phase: PHASE3 • Sponsor: Rigmor Højland Jensen • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Radioactive microspheres aim to shrink stubborn liver tumors
Disease control Not yet recruitingThis is a prospective, open-label, single-arm, investigator-initiated study designed to evaluate the safety and efficacy of NRT6003 Injection, a yttrium-90 carbon microsphere product, administered by selective internal radiation therapy in previously treated patients with hepatoc…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New wound dressings aim to heal stubborn diabetic and leg ulcers
Disease control Recruiting nowCAMPR-II Trial: A multicenter hybrid platform trial comparing the effects of a prospective cohort treated with a saline-hydrated allogeneic dual-layer amniotic membrane product or a synthetic, resorbable polymeric wound matrix to a coarsened exact matched retrospective control co…
Phase: NA • Sponsor: Capsicure, LLC • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New pill could tame phenylketonuria by blocking amino acid absorption
Disease control Recruiting nowThis study is a Phase I single ascending dose clinical trial in which healthy adult volunteers were administered single oral doses of GenSci144 tablets at different levels. It was conducted using a randomized, double-blind, placebo-controlled design, primarily to evaluate the dru…
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a quick scope after surgery prevent dangerous leaks?
Diagnosis Recruiting nowThe goal of this clinical trial is to learn whether early postoperative colonoscopy is valuable in the early diagnosis of anastomotic leakage after surgery for low colorectal cancer.The main questions it aims to answer are: 1. Will the median diagnosis time of AL in the interven…
Phase: NA • Sponsor: Nanchong Central Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Experimental vaccine combo takes on tough pancreatic cancer
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety and preliminary effectiveness of a new combination therapy in patients with advanced pancreatic cancer. The main questions it aims to answer are: 1. Is the combination of the peptide nanovaccine (ONVAX-01), an anti-PD-1 …
Phase: PHASE1 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
AI could help doctors identify snakes faster to treat bites
Diagnosis ENROLLING_BY_INVITATIONThis multicenter prospective observational study aims to develop and validate a deep learning-based artificial intelligence snake species identification system, and evaluate its clinical application efficacy in real-world emergency snakebite treatment scenarios. The primary resea…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Ancient toothbrush plant tested as a modern pulp saver
Disease control Not yet recruitingPulpotomy has emerged as a conservative treatment option for mature permanent teeth with irreversible pulpitis, aiming to preserve pulp vitality while avoiding the limitations of conventional root canal treatment. Mineral Trioxide Aggregate (MTA) is currently considered the gold …
Phase: NA • Sponsor: Postgraduate Medical Institute, Lahore • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Laser acupuncture may ease common knee pain without drugs
Symptom relief Not yet recruitingPatellofemoral pain syndrome (PFPS) is among the most prevalent forms of knee discomfort. The main complaint is typically anterior knee pain, which gets worse while jumping, bending knee, going up or down stairs, or sitting for long periods of time with bent knee. Teens and early…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a few minutes of special breathing help Parkinson's patients speak louder and move better?
Symptom relief Recruiting nowParkinsonism impairs upper airway and axial motor control, leading to disordered breathing, reduced speech volume, and ineffective cough. Symptoms are poorly addressed by current therapies. This randomized pilot trial tests whether a single session of acute intermittent hypercapn…
Phase: NA • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Brain surgery in children: what predicts a good recovery?
Disease control Recruiting nowAcute extradural hematoma (EDH) is a potentially life-threatening neurosurgical emergency in children, commonly resulting from traumatic head injury. Early diagnosis and timely surgical intervention are critical factors influencing neurological recovery and overall outcome. Despi…
Sponsor: Sohag University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can an RNA shot teach the immune system to ignore cedar pollen?
Symptom relief Recruiting nowThis is a Phase 1, first-in-human clinical trial to test a new treatment called ITI-9001 for people with allergies to Japanese Red Cedar (JRC) pollen-a common cause of seasonal allergies in Japan. The main goals are to find out if ITI-9001 is safe, how well people tolerate it, an…
Phase: PHASE1 • Sponsor: Immunomic Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
AI vs. rare diseases: can a computer Out-Diagnose doctors?
Diagnosis Not yet recruitingA multicentre, randomised diagnostic accuracy study to evaluate whether the rare disease-specific AI can improve diagnostic accuracy and efficiency for physicians managing real-world clinical cases.
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
New heart mapping could make AFib ablation more effective
Disease control Recruiting nowAtrial fibrillation (AF) is a common heart rhythm disorder. While catheter ablation is an effective treatment, many patients still experience AF recurrence after the procedure. One major reason is that the mechanisms that maintain AF are not fully understood. Research suggests th…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Ancient needle trick may help stroke survivors swallow again
Symptom relief Not yet recruitingDysphagia is one of the most common and serious complications following stroke. It can easily lead to aspiration and aspiration pneumonia, reduce patients' quality of life, increase healthcare costs, and result in high mortality rates, making it a clinical issue that urgently nee…
Phase: NA • Sponsor: The Third People's Hospital of Huizhou • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a VR driving test spot early dementia? new study says yes
Knowledge-focused Not yet recruitingDriving ability in older adults is essential for independent mobility and social participation, yet declines under high cognitive load or distraction often lead to visual attention failures such as "look-but-fail-to-see," increasing crash risk. Older adults and individuals with m…
Sponsor: National Cheng-Kung University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Parkinson's patients test VR and brain games to steady their steps
Disease control Not yet recruitingThis prospective, randomized, single-blind, controlled clinical trial aims to evaluate and compare the efficacy of cognitive-based balance rehabilitation delivered via immersive Virtual Reality (VR) versus traditional Dual-Task Training (DTT) on balance, gait, cognitive functions…
Phase: NA • Sponsor: Bezmialem Vakif University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New bladder cancer drug SYS6002 takes on PADCEV in Head-to-Head trial
Disease control Not yet recruitingThis study is a randomized, open-label, controlled, multicenter phase II clinical trial, which aims to evaluate the safety and efficacy of SYS6002 versus enfortumab vedotin in the treatment of participants with advanced urothelial carcinoma. This study has not yet been submitted…
Phase: PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo therapy aims to boost red blood cells in bone marrow disease
Disease control Not yet recruitingThis phase II MyeloMATCH treatment trial tests luspatercep with or without epoetin alfa or emavusertib for the treatment of low risk myelodysplasia and anemia. Biological therapies, such as luspatercep, use substances made from living organisms that may attack specific cancer cel…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC